Loading company
Staar Surgical Co.
STAA · Nasdaq · ·
Next earnings: November 4, 2026
$22.45+7.5%Sep 29 close
- 1M
- +1.5%
- 6M
- +22.4%
- 1Y
- -16.4%
- 5Y
- -83.5%
STAA · Nasdaq · ·
Next earnings: November 4, 2026
$22.45+7.5%Sep 29 close
Staar Surgical Co. is scheduled to report next on November 4, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending July 3, 2026, against the same quarter a year earlier.
| Measure | 3 months toJul 3, 2026 | 3 months toJun 27, 2025 | Change |
|---|---|---|---|
| Total Revenue | $93.5M | $44.3M | +111.04% |
| Profit | $8.1M | -$16.8M | +147.93% |
| Profit per share | $0.16 | -$0.34 | +147.06% |
| Free Cash Flow | $19.2M | -$29M | +166.10% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
STAAR Surgical (NASDAQ: STAA) is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Staar Surgical Co.’s Item 2.02 8-K filed August 12, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Staar Surgical Co. has no earnings call transcript available.